Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259008 · ClinicalTrials.gov registry record · Phase 4
Safety of Manganese Restriction in Neonatal Parenteral Nutrition
A Phase 4 study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT04259008: Completed Phase 4 study, sponsored by Sharp HealthCare.
NCT04259008 is a Phase 4 study that has completed, run by Sharp HealthCare. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259008, a Phase 4 study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
Participants will be \<= 32 weeks gestational age (GA) neonates randomized to parenteral nutrition (PN) prepared with standard dose trace elements or to PN prepared with standard trace elements minus manganese.
Interventions
- OTHER Manganese omission
- OTHER 5 mCg/kg/day manganese from "Multitrace-4 Neonatal."
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2021-07-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04259008
The ClinicalTrials.gov registry entry for NCT04259008 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manganese omission is the first listed.
NCT04259008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04259008 about?
NCT04259008 is a clinical study titled "Safety of Manganese Restriction in Neonatal Parenteral Nutrition". Participants will be \<= 32 weeks gestational age (GA) neonates randomized to parenteral nutrition (PN) prepared with standard dose trace elements or to PN prepared with standard trace elements minus manganese.
What is the current status of trial NCT04259008?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2020-06-11. Estimated completion is 2021-07-22.
What interventions are being tested in trial NCT04259008?
The interventions under investigation include: Manganese omission (OTHER), 5 mCg/kg/day manganese from "Multitrace-4 Neonatal." (OTHER).
Who is sponsoring clinical trial NCT04259008?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.